Evidence map›Paper›PMID 38732308›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics.

Constanza Bravo, Geovanna Vizcarra, Antonia Sánchez, Francisca Cárdenas, Juan Pablo Canales, Héctor Ugalde, Alfredo Parra-Lucares

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Constanza BravoCardiovascular Department, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Geovanna VizcarraCardiovascular Department, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Antonia SánchezFaculty of Medicine, School of Medicine, Universidad de Chile, Santiago 8380456, Chile.
Francisca CárdenasFaculty of Medicine, School of Medicine, Universidad de Chile, Santiago 8380456, Chile.
Juan Pablo CanalesFaculty of Medicine, School of Medicine, Universidad de Chile, Santiago 8380456, Chile.
Héctor UgaldeCardiovascular Department, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Alfredo Parra-LucaresCardiovascular Department, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.ORCID 0000-0002-5888-844X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Standard troponin has long been pivotal in diagnosing coronary syndrome, especially Non-ST-Segment Elevation Myocardial Infarction (NSTEMI). The recent introduction of high-sensitivity troponin (hs-cTnI) has elevated it to the gold standard. Yet, its nuanced role in predicting angiographic lesions and clinical outcomes, notably in specific populations like obesity, remains underexplored.

Indexed as

acute heart failurecoronary artery diseaseNSTEMIobesitytroponin

Identifiers

PMID38732308
PMCPMC11083280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.